LumiraDX Ltd.
(NASDAQ : LMDX)

( )
LMDX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.04%593.611.0%$883.66m
DHRDanaher Corp. 0.65%289.130.7%$751.74m
MDTMedtronic Plc 0.12%107.930.6%$696.83m
ABTAbbott Laboratories 0.29%126.460.8%$681.29m
ISRGIntuitive Surgical, Inc. -0.50%292.000.8%$448.30m
ALGNAlign Technology, Inc. 0.00%497.596.4%$363.70m
DXCMDexCom, Inc. 0.00%435.237.8%$335.93m
SYKStryker Corp. 0.06%258.461.3%$314.36m
BSXBoston Scientific Corp. 0.32%44.191.0%$312.36m
BDXBecton, Dickinson & Co. 0.03%263.941.0%$290.01m
AAgilent Technologies, Inc. -0.04%140.431.6%$232.48m
EWEdwards Lifesciences Corp. 0.00%116.160.4%$223.32m
IDXXIDEXX Laboratories, Inc. 1.50%526.943.8%$208.08m
PKIPerkinElmer, Inc. (United States) 0.04%176.872.4%$189.33m
ZBHZimmer Biomet Holdings, Inc. 0.04%123.321.7%$188.19m

Company Profile

LumiraDX Ltd. engages in the provision of next-generation POC diagnostic company, which focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. The firm developed and launched the platform, which is an integrated system comprised of a small, versatile POC instrument, or Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in London, the United Kingdom.